Key result
Postoperative troponin elevation links to substantially higher 30-day mortality, supporting structured surveillance and management.
Why the study?
Postoperative troponin elevation after non-cardiac surgery is common, frequently asymptomatic, and associated with increased short-term mortality, yet remains challenging to interpret and is often overlooked in surgical practice.
Does a structured stepwise approach to perioperative troponin surveillance improve detection and management of myocardial injury in adults undergoing non-cardiac surgery?
Does a structured stepwise approach to perioperative troponin surveillance improve detection and management of myocardial injury in adults undergoing non-cardiac surgery?
Postoperative troponin elevation is a powerful prognostic marker, and routine surveillance in high-risk patients enables early detection and potentially life-saving management of silent myocardial injury.
Supports targeted troponin surveillance in high-risk non-cardiac surgery; leaves open whether structured protocols improve outcomes.
INTRODUCTION: Cardiac troponin is a highly sensitive marker of myocardial injury, although its interpretation after non-cardiac surgery remains challenging. Postoperative troponin elevation is common, frequently asymptomatic and associated with a markedly increased risk of short-term mortality, yet it is often misinterpreted or overlooked in surgical practice. METHODS: We performed a narrative review of contemporary evidence and international guidelines addressing perioperative troponin measurement, myocardial injury after non-cardiac surgery (MINS), and perioperative myocardial infarction (MI), with a focus on their relevance to surgical teams. MEDLINE and Embase were searched for adult English-language studies, prioritising the past 10-15 years and key consensus statements. Studies relevant to postoperative outcomes, risk stratification and management were synthesised into a pragmatic stepwise approach for surgical teams. FINDINGS: Studies including VISION and POISE demonstrate that even modest postoperative troponin rises are independently associated with substantially increased 30-day mortality, most often in the absence of ischaemic symptoms. Differentiating type 1 MI, type 2 MI and non-ischaemic myocardial injury is difficult in the perioperative setting because clinical features, electrocardiography and baseline troponin values are frequently non-specific. Contemporary European and North American guidelines now support targeted perioperative troponin surveillance in high-risk patients to allow early detection and risk stratification. CONCLUSIONS: Postoperative troponin elevation represents a powerful prognostic marker rather than a single disease entity. A structured, stepwise approach incorporating preoperative risk assessment, serial troponin measurement, clinical correlation and selective imaging can help surgical teams distinguish clinically significant myocardial injury from chronic or non-ischaemic elevation, enabling timely multidisciplinary management and potentially improving outcomes.
No takes yet. Share an insight, caveat, or question.
Dave et al. (2026) conducted a review in Myocardial injury after non-cardiac surgery (MINS). Postoperative troponin elevation was evaluated. Postoperative troponin elevation is a powerful prognostic marker associated with substantially increased 30-day mortality, warranting a structured, stepwise approach for early detection and management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: